- Investigators
- John S Anderson, Jason A Piraino
- Ages
- 18 Years - N/A
- Sexes
- All
Clinical trials
-
A Phase 3, Double-blind, Randomized, Placebo-controlled Study to Assess the Efficacy, Safety, and Tolerability of EN3835 vs Placebo in the Treatment of Plantar Fibromatosis (PFI) (Also Known as Ledderhose Disease) -
SWAP 7 - Investigator
- Francesco Franchi
- Ages
- 18 Years - 99 Years
- Sexes
- All
-
ReMEDy2: A Phase 2/3 Adaptive Design, Randomized Double-blind Placebo-controlled Study to Evaluate the Safety and Efficacy of DM199 for the Treatment of Acute Ischemic Stroke - Investigators
- Benjamin T Alwood, Scott L Silliman
- Ages
- 18 Years - 90 Years
- Sexes
- All
-
ReMEDy2: A Phase 2/3 Adaptive Design, Randomized Double-blind Placebo-controlled Study to Evaluate the Safety and Efficacy of DM199 for the Treatment of Acute Ischemic Stroke - Investigators
- Benjamin T Alwood, Scott L Silliman
- Ages
- 18 Years - 90 Years
- Sexes
- All
-
Open-Label, Phase 2, Multiple Dose Study to Evaluate the Pharmacodynamic Effects, Safety, and Tolerability of Patiromer in Children under 12 Years of Age with Hyperkalaemia - Investigator
- Mohammad Ilyas
- Ages
- 0 Years - 12 Years
- Sexes
- All
-
Placebo-controlled Study to Evaluate the Efficacy and Safety of Tozorakimab in Patients Hospitalized for Viral Lung Infection Requiring Supplemental Oxygen - Investigator
- Tracy T Ashby
- Ages
- 18 Years - NA Years
- Sexes
- All
-
Selatogrel Outcome Study in suspected Acute Myocardial Infarction (SOS-AMI) - Investigator
- Francesco Franchi
- Ages
- 18 Years - N/A
- Sexes
- All
-
Switching from Clopidogrel to Low-dose Prasugrel in Patients at Dual-risk Following Percutaneous Coronary Intervention: TAILOR-BLEED-2 study - Investigators
- Dominick J Angiolillo, Luis G Ortega Paz
- Ages
- 18 Years - 99 Years
- Sexes
- All
-
STOMP study - Investigator
- Mobeen H Rathore
- Ages
- 7 Years - 60 Years
- Sexes
- All
-
The MAGICAL SV Randomized Clinical Trial - Investigator
- Daniel E Soffer
- Ages
- 18 Years - 99 Years
- Sexes
- All